Provide your temperature documentation and photos
In summary, the improvements in CV outcomes associated with semaglutide treatment highlight its potential as a therapeutic option for individuals with overweight or obesity and established ASCVD and concurrent MASH
5001.000 mg als Einzeldosis bzw
The exact dose depends on your weight, comorbidities, kidney function, and disease activity, and should always be determined by your prescribing physician
Keep in mind that there are some GLP-1 side effects, the most common being nausea, vomiting, diarrhoea and loss of appetite, along with dizziness, infections, increased heart rate, headaches, indigestion and mild itchiness where youre injected
It has minimal direct impact on estrogen, progesterone, cortisol, or prolactin, which is a significant advantage for women